Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-07-18

Clinical Trial Update: Fludarabine and Cyclophosphamide Followed by Peripheral Stem Cell Transplant in Treating Patients With Leukemia or Lymphoma [Phase 2]

View source ↗

Summary

This Phase 2 trial evaluates conditioning with fludarabine and cyclophosphamide followed by peripheral stem cell transplant in patients with leukemia or lymphom…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CYCLOPHOSPHAMIDE (Cyclophosphamide)
  • Fludarabine (Fludarabine)

Snippet

Sponsor: Cancer and Leukemia Group B | Conditions: Leukemia, Lymphoma | Phase 2 | Status: COMPLETED